<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Reviews and guidelines</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Reviews and guidelines.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/collections/reviews-and-guidelines.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Factors that impact on healthcare workers&apos; adherence with infection prevention and control (IPC) guidelines for COVID-19: a qualitative evidence synthesis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The review offers implications for practice, including communication strategies, training, and supply provision, intended to support policymakers and decision-makers managing IPC during ongoing and future pandemic responses.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Influenza</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Convalescent Plasma Restores Viral Clearance After Anti-Spike Monoclonal Antibody Failure in Immunocompromised COVID-19 Patients: A Systematic Review and Meta-Analysis of Individual Patient Data.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings concern a treatment option for immunocompromised patients with persistent infection after monoclonal antibody failure, but the supplied abstract does not establish comparative effectiveness or causality.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Timing, Titre, and Host Determinants of Convalescent Plasma Efficacy in COVID-19: A Systematic Review With Design-Stratified Narrative Synthesis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Clarifying these operational parameters supports more precise therapeutic allocation and establishes a methodological framework for managing future infectious disease crises.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Interferon-gamma release assays versus tuberculin skin test for latent tuberculosis infection positivity among healthcare workers and first responders: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108949-15282287/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108949-15282287/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Latent tuberculosis infection remains common among healthcare workers, and positivity estimates vary substantially by diagnostic method. The association of TST positivity with BCG vaccination suggests IGRA may offer greater specificity for screening BCG-vaccinated occupational groups.</description>
    <category>Tuberculosis</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>These aggregated results guide international immunization planning and highlight structural improvements needed for future outbreak responses, such as unified research methodologies and integrated health databases.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta-Analysis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-jvh-70222-ec6cd0c2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-jvh-70222-ec6cd0c2/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The abstract characterizes HBV, HCV, HDV, MASLD, and alcohol use as preventable causes or contributors considered in relation to liver cancer. It states that the findings support integrating hepatocellular carcinoma surveillance into management of viral hepatitis.</description>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>Surveillance</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Acceptability and Effectiveness of Point-of-Care HCV Testing in Low- and Middle-Income Countries: A Systematic Review.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-liv-70844-6b9da0ae/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-liv-70844-6b9da0ae/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Decentralized HCV testing and care models may improve testing uptake and treatment success in LMICs, addressing the reliance on costly and technically demanding centralized laboratory services. High retention in care and cure rates support the potential for these models to advance HCV elimination goals in resource-limited settings.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Streptococcus suis meningitis complicated with communicating hydrocephalus: complete clinical and radiological resolution with non-neurosurgical management—A case report</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1888345-083371ad/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1888345-083371ad/</guid>
    <pubDate>Fri, 28 Aug 2026 00:00:00 GMT</pubDate>
    <description>The case suggests that contrast-enhanced MRI for accurate hydrocephalus subtyping and rapid pathogen identification via metagenomic sequencing may inform decisions about non-neurosurgical management in selected S. suis meningitis cases with communicating hydrocephalus.</description>
    <category>Streptococcus suis</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Post-Infectious Cerebellitis: A Systematic Review of Aetiology, Clinical Presentation, Treatment, and Outcomes.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review maps the clinical spectrum of an immune-mediated post-infectious neurological syndrome across age groups and common viral triggers, which may inform recognition of ataxia syndromes following infection.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Varicella</category>
    <category>Influenza</category>
    <category>Zoster</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Hearing aids for mild to moderate hearing loss in adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd012023-pub3-623f5813/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd012023-pub3-623f5813/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>Findings align with routine first-line clinical provision of hearing aids to adults seeking help for hearing difficulties, while signalling ongoing uncertainty around benefits for mental health and cognition.</description>
    <category>AIDS</category>
    <category>Noise-induced hearing loss</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>The effect of mefloquine dose on outcome of uncomplicated falciparum malaria treated with artesunate-mefloquine: a WWARN systematic review and individual patient data meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12936-026-05963-4-1502247a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12936-026-05963-4-1502247a/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The results indicate that while the regimen remains effective, age-specific tolerability issues may constrain dosing adjustments in young children.</description>
    <category>Malaria</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Hemoadsorption Therapy for Expanded Dengue Syndrome Patients : A Case Series Study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3329-jcmcta-v37i1-91645-b980d6a0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3329-jcmcta-v37i1-91645-b980d6a0/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Expanded dengue syndrome represents a rare but severe manifestation of dengue infection with multi-organ involvement and high fatality risk. The case series suggests hemoadsorption may offer a treatment option when standard intensive care fails, though the evidence base is limited to three cases.</description>
    <category>Dengue</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Interventions for preventing dengue: a mapping review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016299-pub2-93bce51c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016299-pub2-93bce51c/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors highlight that the main challenge is not a lack of primary studies but the absence of strategic synthesis aligned with decision-making, and call for greater emphasis on epidemiological and implementation outcomes beyond entomological endpoints to support scalable dengue control, particularly in endemic and resource-constrained settings.</description>
    <category>Dengue</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Management of neonates born to mothers with reactive serologic tests for syphilis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001234-117d9b89/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001234-117d9b89/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review is framed around the U.S. resurgence of maternal and congenital syphilis, noting associated neonatal morbidity and mortality and calling for more practical, safe management approaches.</description>
    <category>Syphilis</category>
    <category>Congenital syphilis</category>
    <category>Syphilis in pregnancy</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Pradefovir mesylate and tenofovir amibufenamide for chronic hepatitis B: a systematic review and pragmatic treatment algorithm</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The manuscript consolidates comparative safety and efficacy data to inform clinical guidelines regarding newly approved nucleotide prodrugs for chronic hepatitis B management.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Do Digital Visual Aids Improve Skin Self-Examination Behaviours? A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Skin self-examination represents a secondary prevention approach for early skin cancer detection. Digital visual aids such as smartphone applications may support broader uptake and maintenance of these examination behaviors.</description>
    <category>AIDS</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Congenital Chagas disease in Mexico: a systematic review of gaps in diagnosis and clinical follow-up</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-trstmh-trag097-2f6c7451/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-trstmh-trag097-2f6c7451/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The disconnect between maternal detection and neonatal treatment reveals a fractured care chain for congenital Chagas disease in Mexico. The authors identify urgent need for universal prenatal screening and standardized molecular diagnostics at birth to fulfill Pan American Health Organization Elimination Initiative commitments.</description>
    <category>Chagas disease</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Dynamics of global mpox epidemics, 1970–2025: a systematic review and meta-analysis of evolving transmissibility and intervention effects</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022252-a4e4e58e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022252-a4e4e58e/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>Monitoring progressive changes in viral spread capabilities underscores the importance of timely, balanced resource distribution paired with localized educational initiatives to mitigate future transmission waves.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag456-d08fe121/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag456-d08fe121/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article provides evidence relevant to treatment policy for uncomplicated Plasmodium falciparum malaria among travelers in the United States. Its findings were reported as informing updated CDC guidance, but this summary does not independently assess that guidance or connect the article with a live surveillance signal.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>Meta-analysis</category>
  </item>
  <item>
    <title>Pulmonary rehabilitation in post-tuberculosis lung disease: a systematic review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1929171-322c5534/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1929171-322c5534/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>PR may represent a non-pharmacologic intervention that could improve functional outcomes and quality of life in the substantial population living with long-term respiratory sequelae of tuberculosis.</description>
    <category>Tuberculosis</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Gut Microbiota Recovery After Direct-Acting Antiviral Therapy for Chronic Hepatitis C: A Systematic Review and Meta-Analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081843-c4d61cac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081843-c4d61cac/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesis highlights unresolved questions regarding how antiviral success translates to intestinal ecosystem restoration, indicating a documented gap in characterizing associated functional and clinical outcomes.</description>
    <category>Hepatitis C</category>
    <category>Chronic hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>CONTEMPORARY CHEST RADIOGRAPHIC MANIFESTATIONS OF PULMONARY TUBERCULOSIS INFECTION WITH HIV/AIDS COINFECTION : A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-70070-msqq9n43-1141f5e6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-70070-msqq9n43-1141f5e6/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>Conventional imaging protocols frequently miss active infections in immunocompromised cohorts, aligning with the authors&apos; emphasis on laboratory confirmation regardless of scan results.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Prevalence of mpox infection among men who have sex with men: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01493-y-6b24b880/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01493-y-6b24b880/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The pronounced regional disparities suggest that targeted geographic strategies and uniform monitoring protocols would enhance future outbreak management and funding distribution.</description>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>From visceral to visible: A systematic review and meta-analysis of post-kala-azar dermal leishmaniasis incidence, risk factors, and treatment outcomes in Eastern Africa</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014666-afa1362a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014666-afa1362a/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Consolidating regional outcome data helps identify modifiable therapeutic variables and highlights gaps in longitudinal tracking necessary for coordinated control initiatives.</description>
    <category>Kala-azar</category>
    <category>Leishmaniasis</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Algorithmic Determinants of Performance Heterogeneity in Whole-Genome Sequencing-Based Prediction of Drug Resistance in Mycobacterium tuberculosis: A Systematic Review and Meta-Analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081824-4cbde115/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081824-4cbde115/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Reducing diagnostic uncertainty for clinical laboratories could facilitate more consistent implementation of genomic resistance testing. Standardized predictive accuracy may support uniform laboratory reporting practices and improve workflow reliability.</description>
    <category>Tuberculosis</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Artificial intelligence and machine learning applications in abdominal tuberculosis diagnosis: A scoping review and translational roadmap</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-35712-aig-123751-6bffb915/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-35712-aig-123751-6bffb915/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Improving detection accuracy for abdominal tuberculosis in resource-constrained environments could mitigate diagnostic delays and support more standardized care delivery pathways.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Seroprevalence of toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and syphilis infections among pregnant women and infants in Malaysia: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-7717-peerj-21632-561aeb09/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-7717-peerj-21632-561aeb09/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The elevated detection rates indicate that routine maternal testing may help identify vulnerable pregnancies and potentially reduce pathogen transfer to offspring.</description>
    <category>Rubella</category>
    <category>Toxoplasmosis</category>
    <category>Syphilis</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Malaria Transmission Via Needle Stick Injury: A Case Report and Systematic Review of the Literature.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-inf-0000000000005376-213986b0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-inf-0000000000005376-213986b0/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings document rare but recognized occupational transmission risk for healthcare workers managing malaria patients, emphasizing the need for standard precautions and post-exposure protocols in clinical settings where malaria is encountered.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Effectiveness of pharmacist-delivered vaccination recommendations for herpes zoster: a systematic review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1884479-77962d08/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1884479-77962d08/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>Enhancing professional guidance within retail pharmacy settings may help mitigate persistent disease burden in aging populations by facilitating greater immunization participation.</description>
    <category>Zoster</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Comparator-Dependent Safety Signals for Incident Systemic Autoimmune Rheumatic Diseases After mRNA COVID-19 Vaccination: A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080706-9ff137c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080706-9ff137c3/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesis addresses ongoing clinical uncertainty regarding potential autoimmune complications following widespread mRNA immunization campaigns. Identifying the gap in extended monitoring frameworks underscores the necessity for sustained epidemiological tracking beyond immediate post-vaccination periods.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>The Application and Impact of Digital Patient Decision Aids in COPD : A Scoping Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</guid>
    <pubDate>Sun, 16 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review frames digital patient decision aids as a possible support for shared decision-making in COPD, with outcome evidence centered on decision quality and user experience measures.</description>
    <category>AIDS</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Determinants of the Seasonal Influenza Vaccination Uptake Among People Aged 50 Years or Above During and After the Pandemic: A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080705-edd7b616/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080705-edd7b616/</guid>
    <pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesized data offers practical guidance for structuring future immunization initiatives and allocating resources to improve coverage in older adult populations.</description>
    <category>Influenza</category>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Vaccine safety</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Phytochemical synergy in artemisia annua herbal tea against malaria: a systematic review of its efficacy and safety in the context of emerging Pfkelch13 resistance</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01486-x-ddb7856c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01486-x-ddb7856c/</guid>
    <pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate>
    <description>The pronounced difference between rapid initial clearance and prolonged parasitological failure positions the botanical infusion as a supplementary measure rather than a definitive monotherapy in endemic regions.</description>
    <category>Malaria</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Evaluating the risk of dapsone hypersensitivity syndrome in Nepalese Leprosy Patients via HLA-B* 13:01 screening using real-time PCR and comparative meta-analysis of international data</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014568-d8a82d06/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014568-d8a82d06/</guid>
    <pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate>
    <description>Routine pre-therapy genetic assessment might lower the burden of severe medication-related complications in endemic regions with limited laboratory infrastructure.</description>
    <category>Leprosy</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Meta-analysis</category>
  </item>
  <item>
    <title>Maternal HIV viral load threshold for guiding extended infant prophylaxis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support a simplified risk-stratified approach to initiating extended infant postnatal prophylaxis, potentially enabling more targeted and resource-efficient prevention of mother-to-child HIV transmission during breastfeeding.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Effectiveness of recombinant zoster vaccine against herpes zoster and postherpetic neuralgia: a systematic review and meta-analysis of post-licensure observational studies</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesized data supply real-world effectiveness metrics that inform health policy regarding vaccine deployment across varied clinical risk categories and aging populations.</description>
    <category>Zoster</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Characteristics of successful and unsuccessful strategies to increase vaccine intention and improve vaccine uptake for U.S. adult populations in the Affordable Care Act era (2010-2025): a systematic review and meta-regression</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128910-5d095fe1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128910-5d095fe1/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Highlights how logistical and organizational modifications can address persistent immunization gaps even after financial barriers are removed.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Measles outbreaks as signals of governance failure: Lessons from Bangladesh&apos;s 2026 immunisation collapse</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128924-527b04f5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128924-527b04f5/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The work indicates that sustaining high immunization levels depends on stable administrative frameworks and clear accountability structures. It recommends evaluating health system management whenever unexpected disease increases occur without clear community resistance.</description>
    <category>Measles</category>
    <category>Rubella</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>A systematic meta-analytic comparative evaluation of seasonal influenza vaccine effectiveness from test-negative design studies in the Northern Hemisphere pre/post COVID-19 pandemic</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128956-49377254/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128956-49377254/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings provide comparative context for interpreting seasonal influenza vaccine-effectiveness estimates across periods and age groups. The abstract indicates that factors other than population immunity could account for the observed differences, so the results do not establish a single explanation.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>A systematic review of knowledge, attitudes, and behaviour towards Japanese encephalitis vaccination</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128999-3ae5f35e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128999-3ae5f35e/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Recognizing these informational deficits and structural hurdles enables stakeholders to design more effective outreach strategies aimed at expanding immunization rates within vulnerable demographics.</description>
    <category>Japanese Encephalitis</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies - an expert meeting report</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13565-3-2bd53b71/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13565-3-2bd53b71/</guid>
    <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
    <description>By establishing uniform evaluation criteria and mapping financial requirements, the report aims to accelerate the deployment of accessible testing instruments that align with regional elimination timelines.</description>
    <category>Chagas disease</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Efficacy and safety of TDF+3TC + EFV‑centric antiretroviral regimens for HIV/HBV co-infection: a systematic review and network meta‑analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13806-5-fad0a9c9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13806-5-fad0a9c9/</guid>
    <pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate>
    <description>The review provides comparative treatment evidence concerning virologic outcomes, CD4+ lymphocyte counts, and reported safety outcomes in people with HIV/HBV co-infection. Its findings may support editorial understanding of the treatment-evidence literature, but the supplied abstract does not establish effectiveness in a broader population or provide implementation, access, or outcome data outside the included trials.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Clinical manifestations and laboratory findings in patients coinfected with dengue virus and SARS-CoV-2: a systematic review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13752-2-27eb012c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13752-2-27eb012c/</guid>
    <pubDate>Fri, 12 Jun 2026 00:00:00 GMT</pubDate>
    <description>Documenting overlapping pathological features aids healthcare providers in recognizing complex presentations and justifies sustained clinical vigilance during suspected dual exposures.</description>
    <category>COVID-19</category>
    <category>Dengue</category>
    <category>SARS</category>
    <category>Hemorrhagic Fever</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Coverage, effectiveness, and sero-positivity of measles-containing vaccines in low- and lower middle-income countries: An umbrella review of systematic reviews and meta-analyses</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108569-f796b9f3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108569-f796b9f3/</guid>
    <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
    <description>Persistent dosing shortfalls and notable attrition between sequential administrations underscore the necessity for targeted programmatic refinements to maintain community protection against viral circulation.</description>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-b09772-e19a270b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-b09772-e19a270b/</guid>
    <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
    <description>The guidance addresses vaccine deployment decisions during a declared international health emergency and reinforces reliance on core public health measures while calling for accelerated development and evaluation of Bundibugyo-specific and broadly protective filovirus vaccines.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Estimating the burden of imported malaria in the Asia Pacific region: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag022-c1c409f9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag022-c1c409f9/</guid>
    <pubDate>Fri, 03 Apr 2026 00:00:00 GMT</pubDate>
    <description>Imported malaria represents a major barrier to achieving and sustaining malaria elimination in the Asia Pacific region, highlighting the need for strengthened cross-border coordination and tailored interventions.</description>
    <category>Malaria</category>
    <category>Surveillance</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf680-1dec909d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf680-1dec909d/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The article provides an evidence-based framework for selecting antiviral treatments for adults with mild to moderate COVID-19. The supplied abstract does not report population-level outcomes or surveillance findings.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal RSV Infections in Immunocompromised Patients</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag117-456ee7d4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag117-456ee7d4/</guid>
    <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
    <description>The article is relevant to vaccination policy and prevention planning for RSV among people with compromised immunity, a group identified in the abstract as experiencing more severe RSV outcomes. It also addresses coadministration with influenza and COVID-19 vaccines and vaccination status among eligible household members.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128251-e9c7aa87/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128251-e9c7aa87/</guid>
    <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
    <description>The review identifies two vaccines with strong seroprotection profiles that can complement mosquito protection and vector control for chikungunya prevention, while highlighting the need for ongoing safety monitoring, particularly in older adults.</description>
    <category>Chikungunya</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Travel medicine</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae : Review of the Literature</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf699-892dcafe/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf699-892dcafe/</guid>
    <pubDate>Tue, 24 Feb 2026 00:00:00 GMT</pubDate>
    <description>Accelerated detection capabilities at the bedside facilitate prompt therapeutic initiation and may help interrupt ongoing community spread of targeted infections.</description>
    <category>Gonorrhea</category>
    <category>Diagnostics</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
</channel>
</rss>
